120 related articles for article (PubMed ID: 36933308)
1. BEX2 is poor prognostic factor and required for cancer stemness in gastric cancer.
Yasumoto A; Fujimori H; Mochizuki M; Shibuya-Takahashi R; Nakamura-Shima M; Shindo N; Yamaguchi K; Fukushi D; Wakui Y; Sugai T; Iwai W; Abue M; Sato I; Satoh K; Katayose Y; Yasuda J; Shibata C; Tamai K
Biochem Biophys Res Commun; 2023 May; 655():59-67. PubMed ID: 36933308
[TBL] [Abstract][Full Text] [Related]
2. BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Fukushi D; Shibuya-Takahashi R; Mochizuki M; Fujimori H; Kogure T; Sugai T; Iwai W; Wakui Y; Abue M; Murakami K; Nakamura Y; Yasuda J; Yamaguchi K; Sugamura K; Shibata C; Katayose Y; Satoh K; Tamai K
Cancer Sci; 2021 Nov; 112(11):4580-4592. PubMed ID: 34424582
[TBL] [Abstract][Full Text] [Related]
3. Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.
Naderi A
Exp Cell Res; 2019 Mar; 376(2):221-226. PubMed ID: 30779920
[TBL] [Abstract][Full Text] [Related]
4. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Naderi A; Liu J; Hughes-Davies L
Mol Cancer; 2010 May; 9():111. PubMed ID: 20482821
[TBL] [Abstract][Full Text] [Related]
5. BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.
Tamai K; Nakamura-Shima M; Shibuya-Takahashi R; Kanno SI; Yasui A; Mochizuki M; Iwai W; Wakui Y; Abue M; Yamamoto K; Miura K; Mizuma M; Unno M; Kawamura S; Sato I; Yasuda J; Yamaguchi K; Sugamura K; Satoh K
Sci Rep; 2020 Dec; 10(1):21592. PubMed ID: 33299012
[TBL] [Abstract][Full Text] [Related]
6. Silencing of brain-expressed X-linked 2 (BEX2) promotes colorectal cancer metastasis through the Hedgehog signaling pathway.
Tan Y; Hu Y; Xiao Q; Tang Y; Chen H; He J; Chen L; Jiang K; Wang Z; Yuan Y; Ding K
Int J Biol Sci; 2020; 16(2):228-238. PubMed ID: 31929751
[TBL] [Abstract][Full Text] [Related]
7. BEX2 promotes tumor proliferation in colorectal cancer.
Hu Y; Xiao Q; Chen H; He J; Tan Y; Liu Y; Wang Z; Yang Q; Shen X; Huang Y; Yuan Y; Ding K
Int J Biol Sci; 2017; 13(3):286-294. PubMed ID: 28367093
[TBL] [Abstract][Full Text] [Related]
8. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.
Bie Q; Sun C; Gong A; Li C; Su Z; Zheng D; Ji X; Wu Y; Guo Q; Wang S; Xu H
Sci Rep; 2016 May; 6():25447. PubMed ID: 27146881
[TBL] [Abstract][Full Text] [Related]
9. Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway.
Meng Q; Zhi T; Chao Y; Nie E; Xu X; Shi Q; Hua L; Wang L; Zhan W; Wang Y; Zhou X; Yu R
J Mol Neurosci; 2014 Jun; 53(2):262-70. PubMed ID: 24390962
[TBL] [Abstract][Full Text] [Related]
10. Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells.
Mu N; Wang Y; Li X; Du Z; Wu Y; Su M; Wang Y; Sun X; Su L; Liu X
Cell Death Dis; 2023 Sep; 14(9):645. PubMed ID: 37777549
[TBL] [Abstract][Full Text] [Related]
11. Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.
Zhou X; Meng Q; Xu X; Zhi T; Shi Q; Wang Y; Yu R
Biochem Biophys Res Commun; 2012 Oct; 427(3):574-80. PubMed ID: 23022184
[TBL] [Abstract][Full Text] [Related]
12. Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis.
Hu Z; Wang Y; Huang F; Chen R; Li C; Wang F; Goto J; Kwiatkowski DJ; Wdzieczak-Bakala J; Tu P; Liu J; Zha X; Zhang H
J Biol Chem; 2015 Oct; 290(42):25756-65. PubMed ID: 26296882
[TBL] [Abstract][Full Text] [Related]
13. Β-catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition.
Nie E; Zhang X; Xie S; Shi Q; Hu J; Meng Q; Zhou X; Yu R
Biochem Biophys Res Commun; 2015 Jan; 456(1):494-9. PubMed ID: 25490384
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein.
Saijoh S; Nakamura-Shima M; Shibuya-Takahashi R; Ito R; Sugawara A; Yamazaki T; Imai T; Asada Y; Matsuura K; Iwai W; Wakui Y; Abue M; Kawamura S; Katayose Y; Fujimori H; Mochizuki M; Yasuda J; Yamaguchi K; Sugamura K; Satoh K; Katori Y; Tamai K
Biochem Biophys Res Commun; 2021 Jan; 537():132-139. PubMed ID: 33412384
[TBL] [Abstract][Full Text] [Related]
15. Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis.
Enjoji S; Yabe R; Tsuji S; Yoshimura K; Kawasaki H; Sakurai M; Sakai Y; Takenouchi H; Yoshino S; Hazama S; Nagano H; Oshima H; Oshima M; Vitek MP; Matsuura T; Hippo Y; Usui T; Ohama T; Sato K
Mol Cancer Res; 2018 Mar; 16(3):554-563. PubMed ID: 29330298
[TBL] [Abstract][Full Text] [Related]
16. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
Naderi A; Liu J; Francis GD
Int J Cancer; 2012 Jan; 130(1):71-82. PubMed ID: 21384344
[TBL] [Abstract][Full Text] [Related]
17. Bex2 is critical for migration and invasion in malignant glioma cells.
Zhou X; Xu X; Meng Q; Hu J; Zhi T; Shi Q; Yu R
J Mol Neurosci; 2013 May; 50(1):78-87. PubMed ID: 22907646
[TBL] [Abstract][Full Text] [Related]
18. PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells.
Mahmoodi F; Akrami H
J Cell Biochem; 2017 Apr; 118(4):851-859. PubMed ID: 27735991
[TBL] [Abstract][Full Text] [Related]
19. BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer.
Naderi A; Liu J; Bennett IC
Int J Cancer; 2010 Apr; 126(7):1596-610. PubMed ID: 19711341
[TBL] [Abstract][Full Text] [Related]
20. BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.
Naderi A; Teschendorff AE; Beigel J; Cariati M; Ellis IO; Brenton JD; Caldas C
Cancer Res; 2007 Jul; 67(14):6725-36. PubMed ID: 17638883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]